In silico structural analysis of carbapenemase variants in Klebsiella pneumoniae: insights for precision drug discovery against multidrug-resistant strains.

BACKGROUND: Carbapenemase-producing Klebsiella pneumoniae severely limits treatment options by inactivating carbapenem and other β-lactam antibiotics. To support precision drug discovery, this study investigates how structural and dynamic differences…

Preview only. Read the full abstract at the source